Details of the Drug

General Information of Drug (ID: DMSLVXA)

Drug Name

V181

Indication

Disease Entry	ICD 11	Status	REF
Dengue fever	1D2Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05507450) A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENVdelta30 [Live, Attenuated]) in Healthy Adults. U.S.National Institutes of Health.